ResearchMoz presents professional and in-depth study of "Global Breast Biopsy Market Size, Status and Forecast 2019-2025".
Biopsies have been the gold standard for pathological assessment of breast cancer. Continuous advancements in breast biopsy technology has made biopsies less invasive and more comfortable for women. To a great deal, the factor stimulating technological advances is prevalence of breast cancer especially among women in developed nations. Rising incidence of the cancer in developing countries and growing awareness of the morbidity of the disease have propelled need for technologies for the early diagnosis early breast cancer. Techniques used for breast biopsy broadly fall under fine needle aspiration biopsy and core needle biopsies, including image-guided percutaneous core-needle biopsies. Vacuum-assisted core biopsy is gathering traction among patient population as the process is notably safe and minimally invasive. High-growth avenues have been witnessed in North America and Europe, and recently in Asia Pacific.
Get Free PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=2162255
A breast biopsy is the procedure of locating a diseased tissue in the breast and collecting the specimen sample of the area for further examination and diagnosis. Breast biopsies are performed by using minimally invasive biopsy systems, owing to minimal disfigurement and pain. Non-invasive biopsy techniques provide preventive measures that assist physicians in diagnosing and treating high-risk breast cancer. This information prevents the application of chemotherapy in breast cancer, reducing the complexities of chemo-radiations. Vacuum assisted breast biopsy devices (VAB), core needle biopsies and fine needle aspiration biopsy are commonly used to perform biopsy procedures.
Approximately 12% women in the U.S. are likely to develop breast cancer during their lifetime. Factors contributing to rise in breast cancer cases is over consumption of alcoholic drinks, lack of physical exercise, improper diet and eating habits, high level of hormonal imbalance & exposure of skin to intense sunlight. However, limited awareness among female population and substandard healthcare facilities especially in developing regions are the factor restraining the growth of breast biopsy market.
North America is expected to account for the largest share of the breast biopsy market, followed by Europe. However, Asia-Pacific is expected to register a higher growth rate during the forecast period. The growth of the breast biopsy market in Asia-Pacific will be centered on China and India.
In 2018, the global Breast Biopsy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Breast Biopsy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Breast Biopsy development in United States, Europe and China.
The key players covered in this study
BD
C.R. Bard
Hologic
Leica Biosystems
Argon Medical Devices
Aurora Imaging
Carestream Health
Cook Medical
Fischer Medical Technologies
Intact Medical
Internazionale Medico Scientifica
Metaltronica
Sectra
Terason
ZAMAR CARE
Market segment by Type, the product can be split into
Needle-Based Biopsy Systems
Breast Biopsy Needles
Biopsy Imaging Guidance Systems
Others
Market segment by Application, split into
Hospitals
ASCs
Research Centers
Make An Enquiry @ https://www.researchmoz.us/enquiry.php?type=E&repid=2162255
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Breast Biopsy status, future forecast, growth opportunity, key market and key players.
To present the Breast Biopsy development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ https://www.linkedin.com/showcase/13221461
Follow me on : https://marketinfo247.wordpress.com/
Biopsies have been the gold standard for pathological assessment of breast cancer. Continuous advancements in breast biopsy technology has made biopsies less invasive and more comfortable for women. To a great deal, the factor stimulating technological advances is prevalence of breast cancer especially among women in developed nations. Rising incidence of the cancer in developing countries and growing awareness of the morbidity of the disease have propelled need for technologies for the early diagnosis early breast cancer. Techniques used for breast biopsy broadly fall under fine needle aspiration biopsy and core needle biopsies, including image-guided percutaneous core-needle biopsies. Vacuum-assisted core biopsy is gathering traction among patient population as the process is notably safe and minimally invasive. High-growth avenues have been witnessed in North America and Europe, and recently in Asia Pacific.
Get Free PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=2162255
A breast biopsy is the procedure of locating a diseased tissue in the breast and collecting the specimen sample of the area for further examination and diagnosis. Breast biopsies are performed by using minimally invasive biopsy systems, owing to minimal disfigurement and pain. Non-invasive biopsy techniques provide preventive measures that assist physicians in diagnosing and treating high-risk breast cancer. This information prevents the application of chemotherapy in breast cancer, reducing the complexities of chemo-radiations. Vacuum assisted breast biopsy devices (VAB), core needle biopsies and fine needle aspiration biopsy are commonly used to perform biopsy procedures.
Approximately 12% women in the U.S. are likely to develop breast cancer during their lifetime. Factors contributing to rise in breast cancer cases is over consumption of alcoholic drinks, lack of physical exercise, improper diet and eating habits, high level of hormonal imbalance & exposure of skin to intense sunlight. However, limited awareness among female population and substandard healthcare facilities especially in developing regions are the factor restraining the growth of breast biopsy market.
North America is expected to account for the largest share of the breast biopsy market, followed by Europe. However, Asia-Pacific is expected to register a higher growth rate during the forecast period. The growth of the breast biopsy market in Asia-Pacific will be centered on China and India.
In 2018, the global Breast Biopsy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Breast Biopsy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Breast Biopsy development in United States, Europe and China.
The key players covered in this study
BD
C.R. Bard
Hologic
Leica Biosystems
Argon Medical Devices
Aurora Imaging
Carestream Health
Cook Medical
Fischer Medical Technologies
Intact Medical
Internazionale Medico Scientifica
Metaltronica
Sectra
Terason
ZAMAR CARE
Market segment by Type, the product can be split into
Needle-Based Biopsy Systems
Breast Biopsy Needles
Biopsy Imaging Guidance Systems
Others
Market segment by Application, split into
Hospitals
ASCs
Research Centers
Make An Enquiry @ https://www.researchmoz.us/enquiry.php?type=E&repid=2162255
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Breast Biopsy status, future forecast, growth opportunity, key market and key players.
To present the Breast Biopsy development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ https://www.linkedin.com/showcase/13221461
Follow me on : https://marketinfo247.wordpress.com/
No comments:
Post a Comment